RA
BIIB icon

Riversedge Advisors’s Biogen BIIB Stock Holding History

Riversedge Advisors’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$377K Buy
1,746
+217
+14% +$41.5K 0.05% 162
2026
Q1 		$280K Buy
1,529
+241
+19% +$44.4K 0.05% 155
2025
Q4 		$227K Buy
+1,288
New +$210K 0.04% 182

Other funds holding BIIB

Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
AIM
Artemis Investment Management Edinburgh, United Kingdom $11.2B AUM 80.72% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
AAMU
AEGON Asset Management (UK) Edinburgh, United Kingdom $9.38B AUM 48.94% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return
ADEF
Adams Diversified Equity Fund Baltimore, Maryland $3.27B AUM 45.57% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
BPC
Banque Pictet & Cie Geneva 73, Switzerland $16B AUM 29.1% 1-Year Est. Return
HP
HealthInvest Partners Stockholm, Sweden $372M AUM 59.89% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return

Riversedge Advisors's BIIB Position: Q2 2026 in Review

Riversedge Advisors increased its Biogen (BIIB) stake by 14% in Q2 2026, buying an estimated $41.5K and bringing the position to 1,746 shares worth $377K. The position accounts for 0.05% of the portfolio, ranked #162.

Riversedge Advisors first reported a position in BIIB in Q4 2025 and has held it in 3 quarters since. 252 funds tracked by Wall St. Rank hold BIIB as of Q2 2026.

  • Riversedge Advisors held 1,746 shares of Biogen worth $377K as of Q2 2026.
  • Riversedge Advisors bought 217 Biogen shares in Q2 2026, an estimated $41.5K.
  • Biogen made up 0.05% of Riversedge Advisors's portfolio in Q2 2026, its #162 holding.
  • Riversedge Advisors first reported a position in Biogen in Q4 2025 and has held it in 3 quarters since.
  • 252 funds tracked by Wall St. Rank held Biogen as of Q2 2026.

Based on Riversedge Advisors's 13F filing for Q2 2026, filed 16 Jul 2026.